VistaShares Artificial Intelligence Supercycle ETF AIS
Set alert
56.96 USD -2.62 -4.40%
At close · Nov 2
57.11 +0.15 +0.26%
After hours · Nov 2, 5:39 PM ET
56.86 Day range 60.49
33.35 52-week range 88.80
- YTD
- +50.81%
- 1 year
- +42.04%
- Open
- 60.59
- Prev close
- 59.58
- Mkt cap
- 185.85M
- Vol
- 2.12M
- Avg vol
- 526.02K
- EPS
- 2.97
- P/E
- 19.17
- Div yield
- 0.00%
More statistics
- Low
- 56.86
- High
- 60.49
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 24.89
- 200-d avg
- 24.89
30m chart
Built from the cached five-day intraday bars.
Signals (6)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| RSI: Oversold | Oct 30, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:55 AM | 6 days ago |
| SMA: Bearish | Oct 26, 3:55 PM | 1 week ago |
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 24.89
- 200-day average
- 24.89
News
- GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
- Anthropic’s $750B Compute Ambition Puts SOXX, SMH and AI Infrastructure ETFs in Focus
- Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization
- DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
- Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases
- 5 ETF Areas That Have Nearly Doubled in First Nine Months of 2026
- The VistaShares Artificial Intelligence Supercycle® ETF (AIS) Hits $1 Billion in Assets
- What's Going On With Silicon Motion Technology Stock Tuesday?
- Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026
- This AI Fund Is Crushing QQQ, and Nvidia Is Barely 2% of It
Your note
Sign in to keep a note on AIS — it syncs with the Stock Master app.